Clinical trial
APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days…
NCT00242281 · Advancis Pharmaceutical Corporation, Industry · Completed
Key facts
| NCT number | NCT00242281 |
|---|---|
| Title | APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat |
| Official title | A Phase III, Multicenter Study to Evaluate the Safety/Efficacy of APC-111 MP Tablet QD vs. Penicillin VK QID Both for 10 Days Treatment of Pharyngitis Secondary to S.Pyogenes in Adolescents/Adults |
| Lead sponsor | Advancis Pharmaceutical Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sore Throat, Pharyngitis, Tonsillitis |
| Intervention type | Drug |
| Interventions | APC-111 MP Tablet, 775 mg |
| Enrollment | 600 |
| Start date | Nov 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Oct 20, 2005 |
| Last update posted | Oct 25, 2006 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: